Omada Health (OMDA) Cash & Equivalents (2024 - 2026)

Omada Health (OMDA) has 3 years of Cash & Equivalents data on file, last reported at $211.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents changed N/A year-over-year to $211.8 million; the trailing twelve-month figure through Mar 2026 stood at $211.8 million (changed N/A YoY), and the FY2025 full-year result was $222.0 million, up 190.65% from the prior year.
• Cash & Equivalents slipped to $211.8 million in Q1 2026, from $222.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $223.1 million in Q2 2025 to a low of $76.4 million in Q4 2024.
• A 3-year average of $186.4 million and a median of $211.8 million in 2026 frame the typical range for Cash & Equivalents.
• Peak annual rise in Cash & Equivalents reached 190.65% in 2025, while the deepest fall reached 190.65% in 2025.
• Tracing OMDA's Cash & Equivalents over 3 years: stood at $76.4 million in 2024, then jumped by 190.65% to $222.0 million in 2025, then dropped by 4.63% to $211.8 million in 2026.
• Business Quant data shows OMDA's Cash & Equivalents at $211.8 million in Q1 2026, $222.0 million in Q4 2025, and $198.6 million in Q3 2025.